OCT 25, 2019 9:43 AM PDT

Novel Therapeutic For Eradicating The Flu Virus

WRITTEN BY: Nouran Amin

Public Health officials have long warned about pandemic pathogens flying fast around the world. One virus already spreads across the globe annually leading to often debilitating infections and even death. However, scientists now have reported a possible therapeutic that can eradicate the virus of influenza.

Every year the flu virus gets smarter and changes its own structure—as a result scientists have to formulate new vaccines that target the most common flying strains. While being vaccinated is the most important protections against the virus, it does not always guarantee not being targeted. Current influenza treating drugs can be effective only when given at the early stages of infection—for example, the therapeutic ‘oseltaminvir’. However, there has been reports of viruses that resist to certain influenza drug treatments like the therapeutic ‘baloxavir’.

Now, researchers have examined a compound named N-hydroxycytidine (NHC) and known for a long time to inhibit RNA viruses like those in the flu. They tweaked NHC to another compound referred to as EIDD-2801 that will convert back to NHC inside the body. The experiment was observed to be promising in ferrets—which are common animal’s models for the influenza.

Science: The flu virus (above) has frustrated scientists with its constant shapeshifting, eluding many vaccines and drugs. JAMES CAVALLINI/SCIENCE SOURCE

“It’s important that they showed a reduction in symptoms in ferrets because it gets much closer to predicting what happens in people,” says Andrew Pavia, an infectious disease expert at the University of Utah in Salt Lake City. “It’s a major step towards developing a drug for humans.”

Findings were reported in Science Translational Medicine.

Source: Science

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 03, 2022
Neuroscience
Promising Epilepsy Treatment Suppresses Neuroinflammation
Promising Epilepsy Treatment Suppresses Neuroinflammation
A team of City University of Hong Kong (CityU) neuroscientists recently identified and developed a new drug candidate fo ...
DEC 14, 2022
Cannabis Sciences
Cannabis Media Coverage Generally Positive Regardless of Clinical Outcome
Cannabis Media Coverage Generally Positive Regardless of Clinical Outcome
A study published in JAMA Open Network shows that cannabis receives significant media coverage regardless of the clinica ...
DEC 21, 2022
Neuroscience
The Antidepressant in Everyone's Medicine Cabinet: The case for the inflammatory theory of depression grows
The Antidepressant in Everyone's Medicine Cabinet: The case for the inflammatory theory of depression grows
Compared to the countless number of serotonin and dopamine-centered depression studies, the kynurenine pathway (KP) hold ...
JAN 04, 2023
Health & Medicine
ACER-001- New Drug to Treat Genetic Disorder
ACER-001- New Drug to Treat Genetic Disorder
Urea cycle disorders (UCDs) are genetic conditions most commonly diagnosed in children that result in the body&rsqu ...
JAN 12, 2023
Drug Discovery & Development
First AI-Discovered Drug has positive results in Phase 1 Trials
First AI-Discovered Drug has positive results in Phase 1 Trials
Insilico Medicine is a clinical-stage artificial-intelligence (AI)-based research and development company seeking to dis ...
JAN 25, 2023
Cancer
Pregnancy After, or During, Breast Cancer
Pregnancy After, or During, Breast Cancer
Breast cancer remains the most common cancer in women in the United States.  Experts estimated 287,850 breast cance ...
Loading Comments...